These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29148208)

  • 1. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.
    Fornaro A; Olivotto I; Rigacci L; Ciaccheri M; Tomberli B; Ferrantini C; Coppini R; Girolami F; Mazzarotto F; Chiostri M; Milli M; Marchionni N; Castelli G
    Eur J Heart Fail; 2018 May; 20(5):898-906. PubMed ID: 29148208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction.
    Citro R; Radano I; Parodi G; Di Vece D; Zito C; Novo G; Provenza G; Bellino M; Prota C; Silverio A; Antonini-Canterin F; Rigo F; Vriz O; Galasso G; Bossone E; Salerno-Uriarte J; Piscione F
    Eur J Heart Fail; 2019 Jun; 21(6):781-789. PubMed ID: 30714660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.
    Rusconi P; Wilkinson JD; Sleeper LA; Lu M; Cox GF; Towbin JA; Colan SD; Webber SA; Canter CE; Ware SM; Hsu DT; Chung WK; Jefferies JL; Cordero C; Lipshultz SE;
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy in a pediatric population: etiology and outcome predictors - a single-center experience.
    Ciuca C; Ragni L; Hasan T; Balducci A; Angeli E; Prandstraller D; Egidy-Assenza G; Donti A; Bonvicini M; Gargiulo GD
    Future Cardiol; 2019 Mar; 15(2):95-107. PubMed ID: 30848673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.
    Nabeta T; Inomata T; Ishii S; Yazaki M; Fujita T; Iida Y; Ikeda Y; Maekawa E; Naruke T; Koitabashi T; Ako J
    Heart Vessels; 2019 Jan; 34(1):95-103. PubMed ID: 29942977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy.
    Lalario A; Del Mestre E; Lo Casto M; Nuzzi V; Manca P; Bromage DI; Barbati G; Merlo M; Sinagra G; Cannatà A
    ESC Heart Fail; 2022 Oct; 9(5):3052-3059. PubMed ID: 35735911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction.
    Li X; Yao Y; Chen Z; Fan S; Hua W; Zhang S; Fan X
    Clin Cardiol; 2019 Jan; 42(1):120-128. PubMed ID: 30447088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.
    Rossi A; Dini FL; Faggiano P; Agricola E; Cicoira M; Frattini S; Simioniuc A; Gullace M; Ghio S; Enriquez-Sarano M; Temporelli PL
    Heart; 2011 Oct; 97(20):1675-80. PubMed ID: 21807656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.
    Halliday BP; Gulati A; Ali A; Newsome S; Lota A; Tayal U; Vassiliou VS; Arzanauskaite M; Izgi C; Krishnathasan K; Singhal A; Chiew K; Gregson J; Frenneaux MP; Cook SA; Pennell DJ; Collins P; Cleland JGF; Prasad SK
    Eur J Heart Fail; 2018 Oct; 20(10):1392-1400. PubMed ID: 29862606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.
    Cannatà A; Fabris E; Merlo M; Artico J; Gentile P; Pio Loco C; Ballaben A; Ramani F; Barbati G; Sinagra G
    Can J Cardiol; 2020 Jan; 36(1):37-44. PubMed ID: 31515085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
    Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM
    Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.
    Eda Y; Nabeta T; Iikura S; Takigami Y; Fujita T; Iida Y; Ikeda Y; Ishii S; Ako J
    ESC Heart Fail; 2024 Jun; 11(3):1463-1471. PubMed ID: 38320776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
    Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.
    Dandel M; Weng Y; Siniawski H; Potapov E; Lehmkuhl HB; Hetzer R
    Circulation; 2005 Aug; 112(9 Suppl):I37-45. PubMed ID: 16159848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.